Skip to main content

From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 11 December

Bell Direct
December 11, 2024

Morning Bell 10 December

Bell Direct
December 10, 2024

Morning Bell 9 December

Bell Direct
December 9, 2024

Weekly Wrap 6 December

Bell Direct
December 6, 2024

Morning Bell 6 December

Bell Direct
December 6, 2024

Morning Bell 5 December

Bell Direct
December 5, 2024

Morning Bell 4 December

Grady Wulff
December 4, 2024

Morning Bel 3 December

Sophia Mavridis
December 3, 2024

Morning Bell 2 December

Grady Wulff
December 2, 2024

Weekly Wrap 29 November

Bell Direct
November 29, 2024

Morning Bell 28 November

Bell Direct
November 28, 2024

Morning Bell 27 November

Bell Direct
November 27, 2024